Clinical and Scientific Assessment of Pain and Painful Disorders
Launched by NATIONAL CENTER FOR COMPLEMENTARY AND INTEGRATIVE HEALTH (NCCIH) · Mar 9, 2016
Trial Information
Current as of July 22, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial aims to better understand pain and how it affects people by studying both those who experience pain and those who do not. Researchers will ask participants about their pain experiences and expose them to different sensations—both pleasant and unpleasant—to gather more information. The study also seeks to identify individuals who may qualify for other research studies at the National Center for Complementary and Integrative Health (NCCIH).
If you or someone you know is 12 years or older and interested in participating, you could be eligible to join. Participants will undergo a screening process by phone and then attend one required visit, which includes a medical history review, a physical exam, questionnaires, and several tests like an MRI and sensory assessments. These visits will help researchers learn more about pain experiences. Over three months, participants may have up to four additional visits for further testing. It's important to note that individuals with certain medical or psychiatric conditions, as well as pregnant women, cannot participate. This study is currently recruiting, and your involvement could contribute to important insights into the nature of pain.
Gender
ALL
Eligibility criteria
- • INCLUSION CRITERIA
- • Are \>= 12 years of age
- • EXCLUSION CRITERIA
- • Have difficulties with communication that make subjective pain assessment impossible or unreliable.
- • Have acute medical or psychiatric health issues that create additional and substantial adverse risks related to study procedures. Medical examples are the acute complications of medical disease, such as asymptomatic hypertensive urgency, diabetic ketoacidosis, symptomatic hyperthyroidism, and unstable angina. Psychiatric examples are the acute complications of psychiatric disease, such as acute mania, paranoid delusions, or having acute panic attacks.
- • Are participating in other ongoing research protocols such that phenotypic measurements would interfere with the conduct of an ongoing protocols or the receipt of a research treatment would influence the phenotypic measurements.
- • Employees or staff that work at NCCIH.
- • Pregnant women
About National Center For Complementary And Integrative Health (Nccih)
The National Center for Complementary and Integrative Health (NCCIH) is a prominent U.S. government agency dedicated to advancing the understanding and integration of complementary and alternative medicine into conventional healthcare. As a part of the National Institutes of Health (NIH), NCCIH supports rigorous scientific research to evaluate the efficacy, safety, and mechanisms of complementary approaches, promoting evidence-based practices in health and wellness. By fostering collaboration among researchers, healthcare providers, and the public, NCCIH aims to enhance health outcomes and empower individuals to make informed decisions about their health and well-being.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Bethesda, Maryland, United States
Patients applied
AW
AS
JT
CB
MB
Trial Officials
Miroslav Backonja, M.D.
Principal Investigator
National Center for Complementary and Integrative Health (NCCIH)
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials